Innopharmax Inc operates within the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Innopharmax Inc with three other
pharmaceutical manufacturers in Asia:
of KOREA (SOUTH)
sales of 6.36 billion Korean Won [US$5.60 million]
of which 95%
was Neogenesis Biomaterials),
Krebs Biochemicals & Industries Limited
(334.12 million Indian Rupees [US$4.51 million]
of which 100%
was Active Pharmaceutical Ingredients), and
Phong Phu Pharmaceutical JSC
based in VIETNAM
(116.92 billion Vietnamese Dong [US$5.09 million]
During the year ended December of 2020, sales at
Innopharmax Inc were 136.88 million Taiwanese Dollars (US$4.92 million).
increase of 61.2%
versus 2019, when the company's sales were 84.89 million Taiwanese Dollars .
This was the third consecutive year of growth at Innopharmax Inc.